Search for: "PROFESSIONAL DRUG COMPANY, INC."
Results 1 - 20
of 715
Sorted by Relevance
|
Sort by Date
20 Dec 2010, 2:34 pm
December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies.Three drug makers - Abbott Laboratories Inc., Roxane Laboratories Inc. and B. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
15 May 2009, 9:15 am
Pharmaceutical giant, Pfizer Inc, will disclose its compensation paid to U.S. healthcare professionals for consulting, speaking engagements and clinical trials. [read post]
6 Apr 2011, 7:53 am
Drug maker Merck & Co. paid $20.4 million to more than 2,000 physicians that discussed the company’s products with other health care professional. [read post]
21 Apr 2009, 3:08 am
Food and Drug Administration announced that it had obtained, "a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. [read post]
5 Aug 2014, 6:30 am
Stack, CPA, Principal, Amaxx Risk Solutions, Inc. is an expert in employer communication systems and part of the Amaxx team helping companies reduce their workers compensation costs by 20% to 50%. [read post]
16 Mar 2010, 11:32 am
The Department of Justice announced on March 16 that Alpharma, Inc., a subsidiary of Bristol, Tennessee-based King Pharmaceuticals, Inc., has paid $42.5 million to settle allegations brought by a whistleblower that it paid health care professionals to prescribe its morphine-derived drug, Kadian. [read post]
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
16 Nov 2009, 5:29 pm
Late Monday evening, deCODE genetics, Inc. filed for chapter 11 bankruptcy protection in Delaware. [read post]
6 Oct 2021, 10:12 am
Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. [read post]
11 Jan 2018, 12:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
27 Feb 2009, 9:03 pm
Nonpracticing New Jersey physician Joseph Piacentile "now makes a living suing drug companies," and the new action in which his name figures against Forest Laboratories follows earlier suits he's helped instigate against Medco Health Solutions, Bristol-Myers Squibb, and Cephalon Inc.... [read post]
28 Mar 2022, 1:37 pm
Co., the insured—a company that managed prescription drug benefit plans—was sued by a former business partner for breach of contract and fraudulent misrepresentation. [read post]
1 Jun 2022, 12:35 pm
This recent FDA action formalizes an April 15, 2022 announcement by TG Therapeutics Inc. that it is pulling Ukoniq from the market after a study showed a possible increased risk of death in patients taking the drug. [read post]
29 Oct 2012, 11:40 am
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
